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Abstract
Background: Selective lamellar corneal transplantation (keratoplasty) has overtaken full thickness penetrating
keratoplasty as the graft choice for endothelial failure. Even more recently eye bank prepared tissues are becoming
increasing popular as a way to reduce the risks of tissue loss and stress during endothelial keratoplasty preparation
in the surgical theatre. This study compares costs between surgeon and eye bank prepared tissues for Descemet’s
stripping automated endothelial keratoplasty (DSAEK) and Descemet’s membrane endothelial keratoplasty (DMEK).
Methods: Retrospective study conducted at the Royal Liverpool University Hospital including endothelial
keratoplasties with a minimum of 6 months follow-up time. Cost analysis included surgical expenses, tissue
acquisition fees, cost of patient’s ward admission and out-patient expenses, including cost of re-bubbling
procedures, costs of visits, anterior segment imaging and optometrist visits within the first 6 months follow-up.
Results: Ninety-eight eyes of 98 patients were included in the study of which 42 underwent DSAEK surgery and 56
DMEK surgery. Cost analysis of surgical expenses in the DSAEK group showed a significant difference between
using surgeon prepared and eye bank prepared tissue (£3866 ± 296 and £4389 ± 360, respectively; p < 0.01) and the
same was found in the DMEK group (£3682 ± 167 and £4162 ± 167 for surgeon prepared and eye bank prepared
tissues, respectively; p < 0.01). Cost of out-patient visits did not differ significantly in either group.
Conclusions: At the Royal Liverpool University Hospital, eye bank prepared tissues had higher surgical expenses
compared to those prepared by the surgeon, while the post-operative care expenses were similar between the two
groups.
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Background
Corneal transplantation is the most successful treatment
in cases of advanced changes in corneal morphology or
transparency. Over the past 20 years, the procedure for
corneal transplantation has evolved from a full thickness
graft (penetrating keratoplasty; PK) to replacement of
only the effected corneal endothelial layer, called endo-
thelial keratoplasty (EK). This is because of rapid
rehabilitation, better ocular integrity and more predict-
able post-operative astigmatism after EK surgery [1–3].
In 2019, 30,650 EK procedures were performed in the
United States of America alone, accounting for more
than 60 % of the total grafts performed [4]. Similar
trends are observed in Europe, with the most recent
published annual European eye bank audit reporting
10,137 EK procedures compared to 8,169 PK emphasiz-
ing the shift towards EK [5, 6].
EK can be broadly divided into two procedures, the
first being Descemet’s stripping automated endothelial
keratoplasty (DSAEK), which is a relatively standardized
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and reproducible technique compared to its counterpart
due to the use of a microkeratome to cut the graft tissue,
thus making it a popular choice of surgery [7]. However,
Descemet’s membrane endothelial keratoplasty (DMEK)
represents the evolution of endothelial surgery into true
lamellar surgery with only the dysfunctional endothe-
lium being replaced by a healthy donor Descemet’s
membrane and endothelium. Tissue preparation in
DMEK has a higher risk of tissue loss, which is reported
in 4.2-8 % of preparations [8, 9]. This association with a
significant learning curve has led to increasing popular-
ity of eye bank prepared pre-stripped and pre-loaded
DMEK grafts to reduce the risks of tissue loss/damage
and stress to the surgeon in the surgical theatre [10–13].
Both types of grafts can be prepared by the surgeon or
by the eye bank technicians. Eye bank prepared tissues
can save graft preparation time during surgery in
addition to obtaining a fully validated tissue with regards
to graft thickness for DSAEK and cell counts for both
DSAEK and DMEK. Eye banks have access to spare tis-
sue in the event of tissue loss due to preparation errors,
which serves as an advantage over tissues prepared in
the surgery, as loss of tissue in surgery leads to
cancellation of surgery. There are several advantages as-
sociated with eye bank prepared tissues, such as the re-
duction in surgery time and instruments required in the
surgery [14], however, it may lead to an increase in the
tissue acquisition fee. Transplantation of a validated
graft and reduced stress in surgery may compensate for
the additional costs [15]. Although both, surgeon and
eye bank prepared EK tissues are being widely accepted,
there is little evidence evaluating the cost effectiveness
of each approach [16], which is a crucial factor especially
for small units with a lower number of transplants per
year.
Different preservation media, preparation methods
and transplantation options are used in different set-
tings. In light of this, the aim of this study was to
present a comparison of transplants using surgeon pre-
pared and eye bank prepared tissues in terms of mean
difference in cost per patient from an NHS England per-
spective, specifically, using the perspective of a large
teaching hospital in the North West of the UK, The
Royal Liverpool University Hospital (RLUH).
Methods
In this retrospective study endothelial keratoplasty sur-
geries performed between January 2018 and August
2019 at the Royal Liverpool University Hospital (Liver-
pool, UK) with a minimum of 6 months follow-up time
and with anterior segment optical coherence tomog-
raphy (OCT) were included. The clinical study was ap-
proved by the Institutional Review Board (A0002786).
We explored all direct medical costs for DSAEK and
DMEK surgeries. Both DSAEK and DMEK surgeries
were divided into surgeon cut (DSAEK) or surgeon
stripped (DMEK) and eye bank prepared tissues (both
pre-cut/stripped and pre-loaded). Eye bank prepared tis-
sues (pre-loaded and pre-cut/stripped) were initially
grouped together since the cost of tissue was the same,
however, given the significant interest in pre-loaded,
sub-group evaluation was also performed.
DSAEK surgeon prepared donor grafts were cut in
theatre immediately before the transplant surgery. Donor
corneas were mounted onto an artificial anterior cham-
ber maintainer (Moria SA). Corneal epithelium was re-
moved by using a polyvinyl alcohol sponge (Merocel,
Alcon Laboratories, Inc.). Then, an automated microker-
atome (Moria, SA) with a 350 mm head was used to re-
move the anterior corneal stroma. Manual dissection of
the peripheral anterior stromal lamella was performed
using a mini 1.25 mm crescent blade (Altomed, Ltd.) to
avoid thicker peripheral graft edges. The remaining
endothelium, Descemet membrane and approximately
100 μm of posterior corneal stroma was then punched
using a Barron donor cornea punch (Hessberg-Barron,
Katena Products, Inc.) at different diameters according
to the surgeon’s choice for each patient.
DMEK surgeon prepared donor grafts were stripped in
theatre immediately before the transplant surgery. The
donor cornea was centered on a punch base using suc-
tion. The tissue was then stained with trypan blue for
approximately 1 min to allow for better visualization.
Then, either the stripping from trabecular meshwork
method, or the scoring of the peripheral endothelium
method was used, as described previously [17].
Eye bank prepared tissues all had quality checks before
shipment with endothelial cell density (ECD) and thick-
ness profile evaluation after preparation. DSAEK eye
bank pre-cut tissues varied in diameter according to sur-
geon requests while DMEK pre-stripped tissues were cut
at 9.5mm in diameter. The DMEK tissues were punched
in theatre immediately before surgery with a Barron
donor cornea punch (Hessberg-Barron, Katena Products,
Inc.) to obtain the optimal size chosen for the specific
patient. Pre-loaded grafts were shipped from the eye
bank directly inside the injector, in a ready-to-use
fashion.
We measured resource use for all medical and surgical
related care along with follow-up outpatient care over a
six months period. Surgical resource use was defined as
the cost associated at the time of surgery and costs re-
lated to patients’ hospital admission. They included tis-
sue acquisition fees, cost of surgery and cost of ward
admission.
Out-patient resource use was defined as all eye health
related service contacts and related costs occurring after
surgery for a six month follow up period. They included
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cost of re-bubbling procedures, cost of out-patient visits,
cost of anterior segment imaging (anterior segment
OCT; AS-OCT) and cost of optometrist visits. The 6-
month post-operative timepoint was chosen since most
EK complications are known to occur over the first 6
months after surgery. Tissue acquisition fees, depending
on the type of tissue received (tissue for PK for surgeon
prepared tissue or pre-cut, pre-stripped or pre-loaded
tissue if prepared by the eye bank) was obtained from
The Venice Eye Bank Foundation.
There are several different methods for costing hos-
pital contacts. Choice of any method needs to be justi-
fied. We took a low costing method as this was a single-
site study. Costs for ward admission, out-patient visits,
optometrist visits and anterior segment imaging were
provided by the Royal Liverpool University hospital.
Costs of EK surgeries and re-bubbling procedures were
obtained from the National NHS tariff [4]. This was a
single site retrospective costing and cohort study com-
bining costing data from the finance department with
NHS tariff costing information. We did not use NHS
reference costs, which could have been an alternative ap-
proach, particularly if this had been a multi-site study.
Even using national reference costs, outcomes can be
different depending on which ones are used [18].
Data on patients’ diagnosis, best corrected visual acuity
(BCVA) pre- and post-operatively and surgeon graft
preparation failure were also collected. All costs were for
in pound sterling and reflect the price for 2018–2019,
which was the same.
Th main outcome was to evaluate the presence of a
between-group difference in mean treatment cost in EKs
between surgeon prepared and eye-bank prepared tis-
sues both at the time of surgery and in the post-
operative period up until 6 months after surgery from an
NHS perspective, specifically, using the perspective of a
large teaching hospital in the North West of the UK
(RLUH).
The statistical analyses were performed using STATA
14.0 (StataCorp, College Station, TX). The normality of
all the data was estimated using the Shapiro-Wilk nor-
mality test. Since data were not normally distributed,
comparisons between surgeon prepared and eye bank
prepared tissues for DSAEK and DMEK were performed
with the two-sample Wilcoxon rank-sum test (Mann-
Whitney). A p-value less than 0.05 was set for statistical
significance. Results are presented as mean ± standard
deviation and interquartile range for continuous variable
and percentages for categorical variables.
Results
A total of 98 consecutive patients (98 eyes) undergoing
DSAEK or DMEK surgery in our tertiary referral centre
between January 2018 and August 2019 were included
after surgeon cut DSAEK (n = 10), eye-bank prepared
DSAEK (n = 32), surgeon cut DMEK (n = 28) and eye-
bank prepared DMEK (n = 28). No tissue wastage was
noted in the surgeon prepared group. In the DSAEK
group, 25 eyes (60 %) had Fuchs’ endothelial corneal dys-
trophy (FECD) and 17 (40 %) had bullous keratopathy.
In the DMEK group 52 (93 %) had FECD and 4 (7 %)
had bullous keratopathy. The mean age of treated pa-
tients was 72.4 ± 10 years and 46 % were male. Mean
corrected distance visual acuity improved from 0.97 ±
0.7 LogMAR preoperatively to 0.37 ± 0.44 LogMAR 6
months postoperatively (Table 1).
The detailed breakdown of costs and acquisition fees
for each type of graft are shown in Table 2. The eye
bank prepared grafts were associated with higher costs
(4389 ± 360, IQR: 4312;4312, min 3699, max 5538) com-
pared to the surgeon prepared grafts (3866 ± 296, IQR:
3682;4295, min 3682, max 4295) in cases of DSAEK (p <
0.01) and DMEK, which were 4162 ± 167 (IQR: 4162;
4162, min 3549, max 4775) and 3682 ± 167 (IQR: 3682;
3682, min 3069, max 4285), in eye bank prepared and
surgeon prepared, respectively (p < 0.01; Fig. 1). This dif-
ference, however, might be partially compensated for by
the time saved in the theatre not having to prepare the
tissues, resulting in a faster surgical time [19].
Outpatient costs of DSAEK and DMEK grafts, show
that there is no difference (p = 0.78 and 0.99, respect-
ively) if prepared by surgeon or by the eye bank in the
first 6 months of follow up, when there are usually more
interventions.
Discussion
In our cost analysis study of endothelial keratoplasty we
identified that surgeries using eye bank prepared grafts
resulted in a significantly higher cost per patient com-
pared with EK using surgeon-prepared grafts in both
DSAEK (p < 0.01) and DMEK (p < 0.01) from an NHS
England perspective, specifically, using the perspective of
a large teaching hospital in the North West of the UK.
We used costs from RLUH as well as tariff costs for
England as a whole. These costs were not weighted by
the market forces factor as for Royal Liverpool Univer-
sity Hospital this was close to 1 (NHS England, 2014
Table 1 Characteristics of our patient cohort
Baseline characteristics
Number 98
Age 72.4 ± 10 [38, 90]
Sex 45 M, 53 F
Reason for graft 77 Fuchs’ Endothelial corneal dystrophy
21 Bullous Keratopathy
Age as mean ± standard deviation. [minimum, maximum], sex is total number
of each male and female
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Table 2 Detailed summary of the cost of every aspect of surgical and outpatient management in the first 6 months after the
operation. Numbers represent the average total cost per patient of each specific activity and are expressed in £ ± standard
deviation. In square brackets there are the interquantile ranges. Numbers in round brackets represents the average number of units
per group. E.g.in the DSAEK surgeon group, on average we performed 2.6 OCT scans for each patient, with a cost per scan of £67
(average total cost per patient: £67 x 2.6 = £174).
Resources Unit Unit cost (£) Details
DSAEK Surgeon DSAEK Bank DMEK Surgeon DMEK Bank
Surgery costs
Graft Tissue 1640 2251 1640 2120 Cost of tissue
Surgery Procedure 1429 1429 1429 1429 Cost of procedure
Ward Day 797 ± 296 [IQR: 613;
1226] (1.3)
709 ± 351 [IQR: 613;
613] (1.15)
613 ± 167 [613;613]
(1)
613 ± 167 [613;613]
(1)
Cost per day of
admission: £613
Total 3866 ± 296 [IQR: 3682;
4295]
4389 ± 360 [IQR: 4312;
4312]
3682 ± 167 [IQR:
3682;3682]




Rebubbling Procedure 0 ± 0 [IQR: 0;0] (0) 50 ± 134 [IQR: 0;0]
(0.13)
14 ± 76 [IQR: 0;0]
(0.04)
0 ± 0 [IQR: 0;0] (0) Cost of RB in theatre:
£400
Follow up Visit 536 ± 133 [IQR: 447;
626] (6)
486 ± 136 [IQR: 447;
581] (5.4)
517 ± 142 [IQR: 447;
626] (5.8)
511 ± 143 [IQR: 357;
626] (5.7)
Cost of visit: £89.40
Optometrist
Visit 79 ± 83 [IQR: 0;158]
(0.5)
74 ±106 [IQR: 0;158]
(0.5)
85 ± 91 [IQR: 0;158]
(0.5)
51 ± 87 [IQR: 0;158]
(0.3)
Cost per visit: £158
OCT Imaging 174 ± 123 [IQR: 67;
268] (2.6)
117 ± 110 [IQR: 34;
201] (1.7)
165 ± 104 [IQR: 67;
201] (2.5)
208 ± 136 [IQR: 134;
335] (3.1)
Cost per scan: £67
Total 789 ± 226 [IQR: 693;
871]
727 ± 322 [IQR: 503;
884]
781 ± 273 [IQR: 593;
917]
769 ± 276 [IQR: 536;
961]
p-value 0.78 0.99
Fig. 1 Graph showing the cost (in £) for different procedures for the surgery and the outpatient department
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[20]). In particular, we found these increased expenses
were mainly due to higher surgical expenses, while no
differences were found in expenses related to the post-
operative care of both groups.
The choice between surgeon and eye bank prepared
grafts should not only be based on the cost. DSAEK has
become a more standardized procedure since the advent
of automated modern keratome techniques [7], however,
lenticules prepared by surgeons still lack validation. This
validation is particularly important since recent evidence
supports a trend towards ultra-thin DSAEK lenticules,
which demonstrate a better visual outcome following
surgery [21, 22] less hyperopic shift [23] and higher
order aberrations [24]. However, preparing and validat-
ing tissue requires infrastructure and time, including ac-
cess to accurate pachymetry, which is unavailable
intraoperatively to most surgeons.
Similarly, many methods for DMEK tissue preparation
have been described including the no touch stripping
technique, pneumatic dissection, hydro-separation, and
others [25–29]. Many of these methods are not validated
in the hands of novice DMEK surgeons and, conse-
quently, the quality of tissues prepared may vary com-
pared to results from standardized techniques [30].
During the learning curve, tissue loss can vary signifi-
cantly and is reported in approximately 4.2-8 % of prepa-
rations [9, 8]. This may result in additional costs and
cancelled surgeries and, most importantly, loss of pre-
cious human donor tissue which is in short supply.
However, with refinement and experience, the propor-
tion of tissue losses can drop to 1 % [31] together with a
reduction in the endothelial cell loss during preparation
[13]. Nevertheless, questions regarding DMEK graft val-
idation persist, particularly in regard to endothelial cell
loss during surgeon preparation. This may support the
use of eye bank prepared controlled and validated tissue
regardless of their higher costs [32].
Although there was no reported tissue loss in our
study during preparation of the DMEK or DSAEK grafts
by surgeons, it is difficult to speculate on endothelial cell
counts or thickness profile. This is largely due to the fact
that surgical theatres are not equipped with instruments
like OCT and inverted or specular microscopes that can
obtain this information.
Furthermore, eye bank-prepared tissues resulted in an
initial increase in costs, this difference can partially be
compensated by the time saved for tissue preparation in
theatre, resulting in shorter theatre time usage [19], thus
giving the chance to accommodate more surgeries in the
same day[19]. Busin et al. demonstrated a potential in-
crease in efficiency using 46 DMEK grafts[10]. The study
reported an average preparation time in the eye bank of
26 min, however the time in theatre from opening the
graft until anterior chamber air injection could be
consistently reduced, potentially freeing up theatre space
[10, 31]. Unfortunately, since theatre time was not mea-
sured in this study, we were unable to quantify the
amount of time saved and to attribute a specific monet-
ary value to this.
This was a partial economic evaluation at group level
based on a retrospective cohort [33–35]. However, we
argue here that our paper could inform a full trial and
full economic evaluation and moves the field on in terms
of choice of methods of surgery and post-operative care.
Evaluation of these costs are also useful to tissue engi-
neers working in the field of corneal transplantation as it
could contribute to a health economics study assessing
the potential market for a tissue engineered graft.
Conclusions
We present a between-group cost analysis alongside a
retrospective cohort study of DSAEK and DMEK sur-
geon prepared and eye bank prepared grafts over the
first 6 months after surgery. We found that EK using eye
bank prepared grafts were more expensive than surgeon
prepared grafts at the Royal Liverpool University Hopsi-
tal. This difference was only evident in the total surgery
cost and mainly linked to the higher acquisition fee of
eye bank-prepared tissues. However, these increased
costs need to be balanced with advantages of shorter
theatre time usage and the availability of tissues with
documented quality control.
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